Drug Shortage Report for XERESE

Last updated on 2017-05-25 History
Report ID 3303
Drug Identification Number 02404044
Brand name XERESE
Common or Proper name XERESE
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C.
Market Status MARKETED
Active Ingredient(s) ACYCLOVIR HYDROCORTISONE
Strength(s) 5% 1%
Dosage form(s) CREAM
Route of administration TOPICAL
Packaging size 5G
ATC code D06BB
ATC description CHEMOTHERAPEUTICS FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-04-24
Actual start date
Estimated end date 2017-05-22
Actual end date 2017-05-24
Shortage status Resolved
Updated date 2017-05-25
Company comments
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-05-25 French Compare
v6 2017-05-25 English Compare
v5 2017-04-25 English Compare
v4 2017-04-07 French Compare
v3 2017-04-07 English Compare
v2 2017-03-17 French Compare
v1 2017-03-17 English Compare